Zyprexa Relprevv Package Insert

HIGHLIGHTS OF PRESCRIBING INFORMATION ...
• ZYPREXA and Fluoxetine in Combination:Also refer to the Drug Interactions section of the package insert for Symbyax.(7.1) • CNS Acting Drugs:Caution should be used when taken in ... Access Document

Drug Use Criteria: Atypical Antipsychotics (long-acting ...
7. Olanzapine extended release injectable suspension (Zyprexa® Relprevv™) package insert. Eli Lilly and Company, January 2017. 8. Paliperidone palmitate extended-release injection suspension (Invega® Sustenna®) package insert. Janssen Pharmaceuticals, June 2017. 9. Paliperidone palmitate extended release suspension (Invega Trinza ... Fetch Full Source

FOR DEEP INTRAMUSCULAR GLUTEAL INJECTION ... - ZYPREXA RELPREVV
It is recommended that gloves are used when reconstituting, as ZYPREXA RELPREVV may be irritating to the skin. Flush with water if contact is made with skin. STEP 2 DETERMINING RECONSTITUTION VOLUME STEP 3 RECONSTITUTING ZYPREXA RELPREVV STEP 4 INJECTING ZYPREXA RELPREVV Refer to the table above to determine the final volume to inject. ... Doc Retrieval

Clinical Policy: Long-Acting Injectable Atypical Antipsychotics
The purpose of this clinical policy is to provide a guide to medical necessity, which is a component of the guidelines used to assist in making coverage decisions and administering ... Fetch Content

Atypical Antipsychotics (long-acting Injectable)
Olanzapine extended release injectable suspension (Zyprexa® Relprevv™) package insert. Eli Lilly and Company, January 2017. 8. Paliperidone palmitate extended-release injection suspension (Invega® Sustenna®) package insert. Janssen Pharmaceuticals, June 2017. ... Document Retrieval

5.60.26 Zyprexa Relprevv Olanzapine 3 18 16 EA - FEP Blue
(olanzapine) must be established prior to initiating treatment with Zyprexa Relprevv (1). Prior approval is required to ensure the safe, clinically appropriate and cost effective use of Zyprexa Relprevv while maintaining optimal therapeutic outcomes. References 1. Zyprexa Relprevv [package insert]. Indianapolis, Indiana: Eli Lilly and Company; ... Visit Document

Olanzapine Pamoate Monograph - United States Department Of ...
Olanzapine pamoate depot is the third atypical antipsychotic to be available as a long-acting intramuscular injection (LA IM) and is approved for the treatment of schizophrenia. Zyprexa Relprevv Package Insert, May 20, 2010. ... Read Document

Paxos Prescribing Pearls From Your Friendly Neighborhood ...
Zyprexa Relprevv [package insert]. January 2018. U.S. Food and Drug Administration, 2015. VMAT2 Inhibitors Valbenazine (Ingrezza®) Tardive dyskinesia (TD) Dosed 40‐80 mg per day Suicidality and depression QT interval prolongation Avoid with CYP inducers* Deutetrabenazine (Austedo®) ... Retrieve Full Source

Therapeutic Class Overview Extended-Release Injectable ...
Maintena ®), aripiprazole lauroxil (Aristada), olanzapine pamoate (Zyprexa Relprevv®), and paliperidone palmitate (Invega Trinza ® ). Partial or total nonadherence with oral antipsychotics in ... Read Full Source

Clinical Policy: Long-acting Injectable Atypical Antipsychotics
®Zyprexa ™ Relprevv (olanzapine extended-release injectable suspension) are medically necessary for members meeting the following criteria: I. Initial Approval Criteria ... Read More

Olanzapine 10 Mg Ingredients - Weavespindye.org
Olanzapine 10 mg ingredients, zyprexa patent expiration date 2011, zyprexa relprevv label, stopping olanzapine side effects, monitoring olanzapine levels, olanzapine 10 mg ingredients Keywords stopping olanzapine side effects, zyprexa fda package insert, zyprexa relprevv label, olanzapine 5mg tablets side effects ... Read Document

AETNA BETTER HEALTH®
• Zyprexa Relprevv 210mg and 300mg: 2 per 28 days • Zyprexa Relprevv 405mg: 1 per 28 days Medically Necessary — A service or benefit is Medically Necessary if it is compensable under the MA Program and if it meets any one of the following standards: The service or benefit will, or is reasonably expected to, prevent the onset of an ... View Full Source

5.60 - FEP Blue
Zyprexa Relprevv is a long-acting atypical antipsychotic used in the treatment of schizophrenia. The exact mechanism by which this drug works is unknown. Zyprexa Relprevv should be Zyprexa Relprevv [package insert]. Indianapolis, Indiana: Eli Lilly and Company; September 2015. ... View Full Source

AETNA BETTER HEALTH®
• Zyprexa Relprevv Authorization guidelines Continuity of Care will be allowed for the following conditions: • Members 18 years or older started on an atypical antipsychotic during a recent hospitalization will receive a 90 day approval (requests for continued use after 90 days are considered renewals). ... Read More

Antipsychotic Medication Use Disclosures In Transitions Of Care
Antipsychotic Medication Use In Transitions of Care A Historical Perspective with Practical Considerations for the Use of Clozapine and Long-Acting Injectables Jolene R. Bostwick, PharmD, BCPS, BCPP No Zyprexa Relprevv Invega Sustenna ... Read Here

ZYPREXA RELPREVV (olanzapine) - Caremark
Zyprexa Relprevv (1). Regulatory Status . FDA-approved indication: Zyprexa Relprevv is a long-acting atypical antipsychotic for intramuscular injection indicated for the treatment of schizophrenia (1). Zyprexa Relprevv has a box warning citing the risk of post-injection delirium/sedation syndrome. ... Read Content

Steven C. Stoner, Pharm.D., BCPP Chair And Clinical Professor ...
Long acting injection (Zyprexa® Relprevv™): restriction on use, in clinical trials, excessive sedation was noted (post injection delirium/sedation syndrome (PDSS), special monitoring required Zyprexa and Zyprexa Relprevv package inserts accessed August 2018. ... View Doc